Tech Company Financing Transactions
Synthace Funding Round
Synthace, based in London, secured $35 million in funding from Horizons Ventures, Sofinnova Ventures and private investors.
Transaction Overview
Company Name
Announced On
11/22/2021
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series C
Investors
Horizons Ventures (Lead Investor) (Patrick Zhang)
Sofinnova Ventures (Lead Investor)
Proceeds Purpose
The investment will fuel commercial and go-to-market (GTM) growth as Synthace continues to radically reinvent the full value chain of life sciences R&D.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
195 Wood Ln. 4th Floor
London, W12 7FQ
UK
London, W12 7FQ
UK
Phone
Website
Email Address
Overview
Synthace is a software company enabling life science, the way it should be done. Delivering a life sciences R&D cloud to scientists who want to innovate faster, the Synthace platform seamlessly automates experimentation and insight sharing so that scientists can focus on asking the most impactful questions and unlock the true potential of biology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guy Levy-Yurista
Chief Financial Officer
Nick McCleery
Chief Scientific Officer
Markus Gershater
VP - Customer Service
Lauren Fovargue
VP - Engineering
Nick Jurascheck
VP - Marketing
Edita Vatenaite
VP - Operations
Zoë Freeman
VP - Product Management
Mathieu Ayel
VP - Sales
Brian Danforth
Browse more venture capital transactions:
Prev: 11/22/2021: Cortex.io venture capital transaction
Next: 11/22/2021: Flytrex venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs